Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Curvature-sensing peptides

Exosome-disrupting peptides for cancer immunotherapy

Nature Materials volume 22, pages 530–531 (2023)Cite this article

Subjects

A curvature-sensing peptide is used to disrupt exosomes for enhanced cancer immunotherapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Exosome-disrupting peptide for cancer immunotherapy.

References

  1. Han, Y., Liu, D. & Li, L. Am. J. Cancer Res. 10, 727–742 (2020).

  2. Tumeh, P. C. et al. Nature 515, 568–571 (2014).

    Article  CAS  Google Scholar 

  3. Yi, M. et al. Mol. Cancer 17, 1–14 (2018).

    Article  Google Scholar 

  4. Chen, G. et al. Nature 560, 382–386 (2018).

    Article  CAS  Google Scholar 

  5. Poggio, M. et al. Cell 177, 414–427.e413 (2019).

    Article  CAS  Google Scholar 

  6. Zhang, H., Lu, J., Liu, J., Zhang, G. & Lu, A. J. Enzyme Inhib. Med. Chem. 35, 1322–1330 (2020).

    Article  CAS  Google Scholar 

  7. Ostrowski, M. et al. Nat. Cell Biol. 12, 19–30 (2010).

    Article  CAS  Google Scholar 

  8. Jackman, J. A. et al. Nat. Mater. 17, 971–977 (2018).

    Article  CAS  Google Scholar 

  9. Shin, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01515-2 (2023).

    Article  Google Scholar 

  10. Papadaki, M. A. et al. Cancers 12, 376 (2020).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA

    Ningqiang Gong, Alex G. Hamilton & Michael J. Mitchell

Authors
  1. Ningqiang Gong
    View author publications

    Search author on:PubMed Google Scholar

  2. Alex G. Hamilton
    View author publications

    Search author on:PubMed Google Scholar

  3. Michael J. Mitchell
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Mitchell.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, N., Hamilton, A.G. & Mitchell, M.J. Exosome-disrupting peptides for cancer immunotherapy. Nat. Mater. 22, 530–531 (2023). https://doi.org/10.1038/s41563-023-01525-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41563-023-01525-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research